Yu-Waye Chu, Chief Medical Officer at FATE THERAPEUTICS INC (FATE), sold 7,825 shares at $5.24 ($41K) on 2023-01-10, disclosed to the SEC on 2023-01-11.
Open-market sale of $41k FATE by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| FATE | SELL | 2023-04-19 | $17K | — | Filing → |
| FATE | SELL | 2022-04-21 | $287K | — | Filing → |
| FATE | SELL | 2022-01-13 | $364K | — | Filing → |